JPS584721A - 皮膚外用剤 - Google Patents
皮膚外用剤Info
- Publication number
- JPS584721A JPS584721A JP10135281A JP10135281A JPS584721A JP S584721 A JPS584721 A JP S584721A JP 10135281 A JP10135281 A JP 10135281A JP 10135281 A JP10135281 A JP 10135281A JP S584721 A JPS584721 A JP S584721A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- sulfonic acid
- pantethine
- pantetheine
- base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 claims description 15
- 241000208140 Acer Species 0.000 claims 1
- 239000003513 alkali Chemical group 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 8
- 239000002674 ointment Substances 0.000 abstract description 7
- 150000001875 compounds Chemical class 0.000 abstract description 6
- 239000003795 chemical substances by application Substances 0.000 abstract description 5
- 230000007794 irritation Effects 0.000 abstract description 5
- 239000000243 solution Substances 0.000 abstract description 5
- 239000002552 dosage form Substances 0.000 abstract description 4
- 239000000843 powder Substances 0.000 abstract description 4
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 abstract description 3
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000005516 coenzyme A Substances 0.000 abstract description 3
- 229940093530 coenzyme a Drugs 0.000 abstract description 3
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 abstract description 3
- 229940057995 liquid paraffin Drugs 0.000 abstract description 2
- 239000000470 constituent Substances 0.000 abstract 3
- 239000004902 Softening Agent Substances 0.000 abstract 1
- 230000037149 energy metabolism Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 229940099259 vaseline Drugs 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 22
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 14
- 239000000203 mixture Substances 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 10
- 206010040880 Skin irritation Diseases 0.000 description 9
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 9
- 231100000475 skin irritation Toxicity 0.000 description 9
- 230000036556 skin irritation Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000009472 formulation Methods 0.000 description 7
- 229960000903 pantethine Drugs 0.000 description 7
- 239000011581 pantethine Substances 0.000 description 7
- 229960001755 resorcinol Drugs 0.000 description 7
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 6
- 235000008975 pantethine Nutrition 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 229940117916 cinnamic aldehyde Drugs 0.000 description 5
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229960003511 macrogol Drugs 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BTEWRTUJKSQHIE-UHFFFAOYSA-N 4-[(2,4-dihydroxyphenyl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound OC1=CC(O)=CC=C1N=NC1=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC(O)=C12 BTEWRTUJKSQHIE-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 208000006550 Mydriasis Diseases 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- -1 liquid paraffin Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10135281A JPS584721A (ja) | 1981-07-01 | 1981-07-01 | 皮膚外用剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10135281A JPS584721A (ja) | 1981-07-01 | 1981-07-01 | 皮膚外用剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS584721A true JPS584721A (ja) | 1983-01-11 |
JPH0354081B2 JPH0354081B2 (enrdf_load_stackoverflow) | 1991-08-19 |
Family
ID=14298437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10135281A Granted JPS584721A (ja) | 1981-07-01 | 1981-07-01 | 皮膚外用剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS584721A (enrdf_load_stackoverflow) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5936606A (ja) * | 1982-08-26 | 1984-02-28 | Sogo Yatsukou Kk | 美白化粧料 |
JPS6064922A (ja) * | 1983-09-21 | 1985-04-13 | Sogo Yatsukou Kk | 皮膚外用剤 |
JP2000204017A (ja) * | 1999-01-13 | 2000-07-25 | Pola Chem Ind Inc | 美白用化粧料 |
US6124406A (en) * | 1998-03-31 | 2000-09-26 | The B. F. Goodrich Company | Blocky chlorinated polyolefins, process for making and use as impact modifier compatibilizer for PVC or CPVC |
US6277915B1 (en) | 1999-09-29 | 2001-08-21 | Pmd Holdings Corporation | Block chlorinated polyolefins for use as impact modifier enhancers for PVC or CPVC |
-
1981
- 1981-07-01 JP JP10135281A patent/JPS584721A/ja active Granted
Non-Patent Citations (3)
Title |
---|
CHEM.ABSTR * |
KHIM-FARM ZH=1981 * |
KHIM-FARM=1981 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5936606A (ja) * | 1982-08-26 | 1984-02-28 | Sogo Yatsukou Kk | 美白化粧料 |
JPS6064922A (ja) * | 1983-09-21 | 1985-04-13 | Sogo Yatsukou Kk | 皮膚外用剤 |
US4749719A (en) * | 1983-09-21 | 1988-06-07 | Sogo Pharmaceutical Company Limited | Method of treating skin pigmentation abnormalities with pantetheine-S-sulfonic acid |
US6124406A (en) * | 1998-03-31 | 2000-09-26 | The B. F. Goodrich Company | Blocky chlorinated polyolefins, process for making and use as impact modifier compatibilizer for PVC or CPVC |
US6204334B1 (en) | 1998-03-31 | 2001-03-20 | The B. F. Goodrich Company | Blocky chlorinated polyolefins, process for making and use as impact modifier compatibilizer for PVC or CPVC |
US6313229B1 (en) | 1998-03-31 | 2001-11-06 | Pmd Group Inc. | Blocky chlorinated polyolefins, process for making and use as impact modifier compatibilizer for PVC or CPVC |
JP2000204017A (ja) * | 1999-01-13 | 2000-07-25 | Pola Chem Ind Inc | 美白用化粧料 |
US6277915B1 (en) | 1999-09-29 | 2001-08-21 | Pmd Holdings Corporation | Block chlorinated polyolefins for use as impact modifier enhancers for PVC or CPVC |
Also Published As
Publication number | Publication date |
---|---|
JPH0354081B2 (enrdf_load_stackoverflow) | 1991-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0100827B1 (en) | Pharmaceutical composition containing an aliphatic aminosulphonic acid | |
JPS6245527A (ja) | 白髪予防、治療剤 | |
JPS584721A (ja) | 皮膚外用剤 | |
JPS6360910A (ja) | 皮膚外用剤 | |
US4035510A (en) | Treatment of acne utilizing N-methyldiethanolamine | |
JPS6127909A (ja) | 皮膚外用剤 | |
US3660296A (en) | Detergent and antiseptic compositions comprising a stock solution of 3 4 4'-trichlorocarbanilide and process for the preparation of the stock solution | |
JP4870431B2 (ja) | 強化された静電気電荷型点鼻製品 | |
KR20190092822A (ko) | 압타민 c를 유효성분으로 포함하는 피부질환 개선 및 치료용 조성물 | |
JPS63183518A (ja) | 毛髪用組成物 | |
JPS63188628A (ja) | 皮膚外用剤 | |
JPS6322510A (ja) | 皮膚外用剤 | |
JPH02311411A (ja) | 養毛料 | |
JPS617206A (ja) | 細胞賦活剤 | |
JPS617205A (ja) | 細胞賦活剤 | |
JPH0137370B2 (enrdf_load_stackoverflow) | ||
JPH01275516A (ja) | ふけ防止剤及び頭髪化粧料 | |
KR0153203B1 (ko) | 피부의 보습 및 각질연화 조성물 | |
JPS60174705A (ja) | 白髪予防、治療剤 | |
JPS6028919A (ja) | 皮膚外用剤 | |
CN115887338B (zh) | 一种具有头皮抗衰功效的组合物及制备方法和应用 | |
JPS6360935A (ja) | 皮脂抑制用外用剤 | |
JPS608222A (ja) | アントラリン安定化組成物と方法 | |
JPH0465044B2 (enrdf_load_stackoverflow) | ||
JPS6028927A (ja) | 皮膚外用剤 |